CKD Bio Corporation
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of L. Lactis CKDB001 in Subjects With Early Alzheimer's Disease (NCT07496021) | CKD Bio Corporation | 2026-02-23 |
| Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial (NCT05804656) | CKD Bio Corporation | 2023-04-13 |
| Safety and Efficacy of CKDB-501B in Subjects With Moderate-to-severe Glabellar Lines (NCT05428930) | CKD Bio Corporation | 2022-06-22 |
| Safety and Efficacy of CKDB-501A in Subjects With Post-stroke Upper Limb Spasticity (NCT05382767) | CKD Bio Corporation | 2022-06-02 |
| Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines (NCT05292638) | CKD Bio Corporation | 2022-02-15 |
Track CKD Bio Corporation automatically
Every clearance here is in the API, with alerts when new ones post.